Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody.
第一作者:
Xianglei,Liu
第一单位:
Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, S843 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, United States; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, Shanghai 200237, China. Electronic address: xianglei922@sina.com.
作者:
DOI
10.1016/j.tranon.2021.101232
PMID
34601396
发布时间
2021-10-25
- 浏览2

Translational oncology
101232页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文